LI Jia, CHEN Weixia, LI Chaoyan, et al. Effects of Weichang’an(胃肠安) on Invasion and Metastasis of Human Gastric Cancer Cells and Pathway of RUFY3 and MAPKs[J]. Journal of Traditional Chinese Medicine2019, 60(7): 592-596.
LI Jia, CHEN Weixia, LI Chaoyan, et al. Effects of Weichang’an(胃肠安) on Invasion and Metastasis of Human Gastric Cancer Cells and Pathway of RUFY3 and MAPKs[J]. Journal of Traditional Chinese Medicine2019, 60(7): 592-596.DOI: 10.13288/j.11-2166/r.2019.07.012.
Effects of Weichang’an(胃肠安) on Invasion and Metastasis of Human Gastric Cancer Cells and Pathway of RUFY3 and MAPKs
Objective To investigate the effects of Weichang’an( 胃肠安) on the invasion and metastasis of gastric cancer and its possible mechanism. Methods The cell proliferation assay was used to screen the drug concentration of Weichang’ an. Samples were divided into blank group
Weichang’ an high dose group
Weichang’ an low dose group and 5-FU group. After cell culture for 24 h
the Weichang’an high and low dose groups were treated with the screening concentration of Weichang’an 100 μl for intervention. The 5-FU group was added with 32 mg/L 5-FU injection 100 μl. The blank group was treated with serum-free culture base 100 μl. The cell proliferation was detected by cell counting kit-8( CCK8) method
and the migration and invasion ability of gastric cancer cells were detected by scratch test and Transwell invasion assay. RUN and FYVE domain protein 3( RUFY3)
phosphorylated mitogen-activated protein kinase( p-MEK)
Twist1
E-cadherin
vimentin
N-cadherin
vascular endothelial growth factor( VEGF)
matrix metalloproteinase 2( MMP2)
matrix metalloproteinase 9( MMP9) protein expression levels were detected by Western blot. Results The concentrations of 500 mg/L and 1000 mg/L Weichang’ an were screened and set as Weichang’an low and high treated dose. After drug administration for 48 h
the cell migration rate of Weichang’ an high
low dose group and 5-FU group was significantly lower than that of the blank group( P < 0. 01). The number of transmembrane cells in the Weichang’an high dose group and 5-FU group was significantly lower than that in the blank group and Weichang’an low dose group( P < 0. 01). The invasive inhibition rates of Weichang’an high and low dose groups were 54. 11% and 7. 65%
respectively
and the invasion inhibition rate of 5-FU group was 47. 88%. Compared with the blank group
the expression of p-ERK and Twist1 protein was decreased in Weichang’ an low dose group
and the expression of E-cadherin protein was increased( P < 0. 05). The expression of RUFY3
p-ERK
pMEK
Twist1. N-cadherin and Vimentin protein in the Weichang’an high dose group was decreased
and the expression of E-cadherin protein was increased( P < 0. 05). Compared with Weichang’an low dose group
the expression of RUFY3
p-MEK and N-cadherin protein in Weichang’ an high dose group was more significantly decreased( P <0. 05). Conclusion Weichang’an can inhibit the invasion and metastasis of gastric cancer
and the effect is best at the concentration of 1000 mg/L. The mechanism may be related to the regulation of invasion and metastasis-related proteins and inhibition of epithelial mesenchymal transition in gastric cancer cells by regulating RUFY3 and MAPKs pathways.
Exploration of the Staged and Phased Differentiation and Treatment Approach for Gastric Cancer Immunotherapy Based on the Theory of Shaoyang (少阳) and Shaoyin (少阴) as the Pivots
Analysis of Traditional Chinese Medicine Pathogenesis Evolution and Metastasis Mechanisms in Advanced Gastric Cancer from the Perspective of the "Phlegm-Toxin Flowing Infusion" Theory
Effect of Liangxue Tuizi Formula (凉血退紫方) on RAF/MEK/ERK Pathway in Skin Tissue and Serum NETs Biomarkers in Henoch-Schönlein Purpura Model Rats with Blood Heat Syndrome
LIU Shenlin's Experience in Treating Gastric Cancer with the Thinking of "Prescription According to Tendency"
Treatment of Postoperative Recurrence and Metastasis of Gastric Cancer Based on the Theory of "Controlling Channels and Collaterals"
Related Author
ZHANG Wenkang
GE Yuansha
LIU Kexin
LI Jie
YAN Xingyu
WANG Wenping
JIANG Yingying
YANG Manxiang
Related Institution
Beijing University of Chinese Medicine
Guang 'anmen Hospital,China Academy of Chinese Medical Sciences
Liaoning Cancer Hospital
Liaoning University of Traditional Chinese Medicine
College of Pediatrics,Henan University of Chinese Medicine